DOCSLIB.ORG

Appendix 1 BNF Codes of Drugs Lists Used to Define Exposure Groups

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Appendix 1 BNF Codes of Drugs Lists Used to Define Exposure Groups Appendix 1 BNF Codes of drugs lists used to define exposure groups. Anticholinergic antipsychotics d411. Chlorpromazine d412. Chlorpromazine d413. Chlorpromazine d414. Chlorpromazine d415. Chlorpromazine d41a. Chlorpromazine d41b. Chlorpromazine d41c. Chlorpromazine d41d. Chlorpromazine d4b1. Perphenazine d4e1. PROMAZINE d4ex. PROMAZINE d4g.. Thioridazine d4g1. Thioridazine d4g2. Thioridazine d4g3. Thioridazine d4g5. Thioridazine d4g7. Thioridazine d4gp. Thioridazine d4gt. Thioridazine d4gu. Thioridazine d4gv. Thioridazine d4gw. Thioridazine d4gz. Thioridazine d4h.. Trifluoperazine d4h1. Trifluoperazine d4h2. Trifluoperazine d4h3. Trifluoperazine d4h4. Trifluoperazine d4hs. Trifluoperazine d4ht. Trifluoperazine d4hu. Trifluoperazine d4hx. Trifluoperazine d4l2. CLOZAPINE d4r1. OLANZAPINE d4r3. OLANZAPINE d4r7. OLANZAPINE d4s1. QUETIAPINE d4s2. QUETIAPINE d4s3. QUETIAPINE d4s5. QUETIAPINE d4ss. QUETIAPINE d4sx. QUETIAPINE Tricyclic antidepressants d7... d71.. Amitriptyline d711. Amitriptyline d712. Amitriptyline d713. Amitriptyline d719. Amitriptyline d71a. Amitriptyline d71b. Amitriptyline d71c. Amitriptyline d71d. Amitriptyline d71e. Amitriptyline d71f. Amitriptyline d71u. Amitriptyline d71v. Amitriptyline d71w. Amitriptyline d71y. Amitriptyline d71z. Amitriptyline d73.. Clomipramine d731. Clomipramine d732. Clomipramine d733. Clomipramine d736. Clomipramine d73s. Clomipramine d73t. Clomipramine d73u. Clomipramine d73v. Clomipramine d73w. Clomipramine d73z. Clomipramine d75.. DOSULEPIN d751. DOSULEPIN d752. DOSULEPIN d755. DOSULEPIN d756. DOSULEPIN d75y. DOSULEPIN d75z. DOSULEPIN d761. Doxepin d762. Doxepin d765. Doxepin d76w. Doxepin d76x. Doxepin d76y. Doxepin d76z. Doxepin d77.. Imipramine d771. Imipramine d772. Imipramine d775. Imipramine d776. Imipramine d79.. Lofepramine d791. Lofepramine d79z. Lofepramine d7a2. Maprotiline d7a3. Maprotiline d7b.. MIANSERIN d7b1. MIANSERIN d7b3. MIANSERIN d7b4. MIANSERIN d7b7. MIANSERIN d7b9. MIANSERIN d7c1. Nortriptyline d7c3. Nortriptyline d7c6. Nortriptyline d7c8. Nortriptyline d7cy. Nortriptyline d7d3. Protriptyline d7f1. Trimipramine d7f2. Trimipramine d7f3. Trimipramine d7fx. Trimipramine d7fy. Trimipramine d7fz. Trimipramine d911. Amitriptyline d913. Nortriptyline,flupenazine d914. Nortriptyline,flupenazine d916. Amitriptyline d917. Amitriptyline Other anticholinergics a4... a41.. Atropine a451. Dicyclomine a453. Dicyclomine a454. Dicyclomine a455. Dicyclomine a45x. Dicyclomine a45y. Dicyclomine a471. HYOSCINE a473. HYOSCINE a47y. HYOSCINE a4b1. Poldine methyl a4by. Poldine methyl a4c1. Propantheline a4c2. Propantheline a821. Atropine a823. Atropine bf2f. HOMATROPINE c831. Brompheniramine c833. Brompheniramine c84.. Chlorphenamine c841. Chlorphenamine c843. Chlorphenamine c84x. Chlorphenamine c84y. Chlorphenamine c851. Clemastine c85y. Clemastine c88 Diphenhydramine c882. Diphenhydramine c885. Diphenhydramine c888. Diphenhydramine c8a.. Hydroxyzine c8i1. Promethazine c8i2. Promethazine c8i9. Promethazine c8iu. Promethazine c8iv. Promethazine c8iw. Promethazine ch2h. Diphenhydramine ci1l. CHLORPHENAMINE ci1p. CHLORPHENAMINE ci1q. CHLORPHENAMINE d28.. Hydroxyzine d284. Hydroxyzine d281. Hydroxyzine d282. Hydroxyzine d28x. Hydroxyzine d28y. Hydroxyzine da6.. Paroxetine da61. Paroxetine da62. Paroxetine da63. Paroxetine da64. Paroxetine da65. Paroxetine da67. Paroxetine da68. Paroxetine dh51. dimenhydrinate diaS. Promethazine dr11. Trihexyphenidyl dr12. Trihexyphenidyl dr13. Trihexyphenidyl dr14. Trihexyphenidyl dr1w. Trihexyphenidyl dr1x. Trihexyphenidyl dr22. Orphenadrine dr2y. Orphenadrine dr51. Anti-muscarinic dr6.. Procyclidine dr63. Procyclidine dr6w. Procyclidine dr6y. Procyclidine gd... Tolterodine gd21. gd41. Flavoxate gd42. Flavoxate gd4y. Flavoxate gd4z. Flavoxate gd92. Terodiline gd9z. Terodiline gda.. Oxybutynin gda1. Oxybutynin gdA1. TOLTERODINE gdA2. TOLTERODINE gda2. Oxybutynin gda3. Oxybutynin gda4. Oxybutynin gdA4. TOLTERODINE gdA5. TOLTERODINE gdA6. TOLTERODINE gda5. Oxybutynin gda6. Oxybutynin gda7. Oxybutynin gda9. Oxybutynin gdaA. Oxybutynin gdaG. Oxybutynin gdaI. Oxybutynin gdax. Oxybutynin gday. Oxybutynin gdaz. Oxybutynin gdB1. TROSPIUM CHLORIDE gdBy. TROSPIUM CHLORIDE gdBz. TROSPIUM CHLORIDE PROPIVERINE gdc1. HYDROCHLORIDE PROPIVERINE gdc2. HYDROCHLORIDE PROPIVERINE gdc4. HYDROCHLORIDE gdd1. SOLIFENACIN SUCCINATE gdd2. SOLIFENACIN SUCCINATE gddy. SOLIFENACIN SUCCINATE gddz. SOLIFENACIN SUCCINATE gdfz. DARIFENACIN gdg2. FESOTERODINE FUMARATE gdgy. FESOTERODINE FUMARATE gdgz. FESOTERODINE FUMARATE j851. METHOCARBAMOL j85y. METHOCARBAMOL o311. Atropine o522. Chlorpromazine Other antidepressants d8... MONOAMINE-OXIDASE INHIBITORS d8... MONOAMINE-OXIDASE INHIBITORS d81.. PHENELZINE d811. NARDIL 15mg tablets d81z. PHENELZINE 15mg tablets d82.. *IPRONIAZID d821. *MARSILID 25mg tablets d822. *MARSILID 50mg tablets d82y. *IPRONIAZID 25mg tablets d82z. *IPRONIAZID 50mg tablets d83.. ISOCARBOXAZID d831. *MARPLAN 10mg tablets d83z. ISOCARBOXAZID 10mg tablets d84.. TRANYLCYPROMINE d841. *PARNATE 10mg tablets d84z. TRANYLCYPROMINE 10mg tablets d85.. MOCLOBEMIDE d851. MANERIX 150mg tablets d852. MOCLOBEMIDE 150mg tablets d853. MANERIX 300mg tablets d854. MOCLOBEMIDE 300mg tablets COMPOUND ANTIDEPRESSANT d9... DRUGS d91.. COMPOUND ANTIDEPRESSANTS A-Z d911. *LIMBITROL 5 capsules d912. *LIMBITROL 10 capsules d913. *MOTIPRESS tablets x28CP d914. *MOTIVAL tablets d915. *PARSTELIN tablets d916. TRIPTAFEN tablets d917. TRIPTAFEN-M tablets da2.. TRYPTOPHAN da21. OPTIMAX 500mg tablets da22. *OPTIMAX 1g/6g powder da23. *OPTIMAX WV 500mg tablets da24. *PACITRON 500mg tablets da2y. TRYPTOPHAN 500mg tablets da2z. *TRYPTOPHAN 1g/6g powder da3.. FLUVOXAMINE MALEATE da31. FAVERIN 50mg tablets da32. FLUVOXAMINE MALEATE 50mg tabs da33. FAVERIN 100mg tablets FLUVOXAMINE MALEATE 100mg da34. tabs da4.. FLUOXETINE HYDROCHLORIDE da41. FLUOXETINE 20mg capsules da42. *PROZAC 20mg capsules x30 da43. FLUOXETINE 20mg/5mL oral liq da44. PROZAC 20mg/5mL oral liquid da45. PROZAC 20mg capsules da46. FLUOXETINE 60mg capsules da47. *PROZAC 60mg capsules da48. *FELICIUM 20mg capsules da49. OXACTIN 20mg capsules da4A. RANFLUTIN 20mg capsules da4B. PROZIT 20mg/5mL oral solution da4C. PROZEP 20mg/5mL oral solution da5.. SERTRALINE HYDROCHLORIDE da51. SERTRALINE 50mg tablets da52. SERTRALINE 100mg tablets da53. LUSTRAL 50mg tablets da54. LUSTRAL 100mg tablets da6.. PAROXETINE HYDROCHLORIDE da61. PAROXETINE 20mg tablets da62. SEROXAT 20mg tablets x30 da63. PAROXETINE 30mg tablets da64. SEROXAT 30mg tablets x30 da65. PAROXETINE 10mg/5mL s/f liq da66. SEROXAT 10mg/5mL s/f liq da67. PAROXETINE 10mg tablets da68. SEROXAT 10mg tablets da7.. VENLAFAXINE da71. VENLAFAXINE 37.5mg tablets da72. VENLAFAXINE 75mg tablets da73. EFEXOR 37.5mg tablets da74. EFEXOR 75mg tablets da75. *VENLAFAXINE 50mg tablets da76. *EFEXOR 50mg tablets da77. VENLAFAXINE 75mg m/r capsules da78. EFEXOR XL 75mg m/r capsules da79. VENLAFAXINE 150mg m/r capsules da7A. EFEXOR XL 150mg m/r capsules da8.. NEFAZODONE da81. *NEFAZODONE HCL 100mg tabs da82. *NEFAZODONE HCL 200mg tabs da83. *DUTONIN 100mg tablets da84. *DUTONIN 200mg tablets da85. *NEFAZODONE initiation tabs pk da86. *DUTONIN initiation tabs pack da9.. CITALOPRAM da91. CITALOPRAM 20mg tablets da92. CIPRAMIL 20mg tablets da93. CITALOPRAM 10mg tablets da94. CIPRAMIL 10mg tablets da95. CITALOPRAM 40mg tablets da96. CIPRAMIL 40mg tablets da97. CIPRAMIL 40mg/mL drops 15mL da98. PAXORAN 10mg tablets da99. PAXORAN 20mg tablets da9A. PAXORAN 40mg tablets da9z. CITALOPRAM 40mg/mL oral drops daA.. REBOXETINE daA1. REBOXETINE 4mg tablets daA2. EDRONAX 4mg tablets daB.. MIRTAZAPINE daB1. MIRTAZAPINE 30mg tablets daB2. *ZISPIN 30mg tablets daB3. MIRTAZAPINE 30mg disp tabs daB4. ZISPIN SOLTAB 30mg disp tabs daB5. MIRTAZAPINE 15mg disp tabs daB6. ZISPIN SOLTAB 15mg disp tabs daB7. MIRTAZAPINE 45mg disp tabs daB8. ZISPIN SOLTAB 45mg disp tabs daBy. MIRTAZAPINE 45mg tablets daBz. MIRTAZAPINE 15mg tablets daC.. ESCITALOPRAM daC1. ESCITALOPRAM 10mg tablets daC2. CIPRALEX 10mg tablets daC3. ESCITALOPRAM 20mg tablets daC4. CIPRALEX 20mg tablets daC5. ESCITALOPRAM 5mg tablets daC6. CIPRALEX 5mg tablets daC7. ESCITALOPRAM 10mg/mL oral dps daC8. CIPRALEX 10mg/mL oral drops du6.. BUPROPION du6.. AMFEBUTAMONE du61. ZYBAN 150mg m/r tablets du6z. BUPROPION HCL 150mg m/r tabs AMFEBUTAMON HCL 150mg m/r du6z. tabs gde.. DULOXETINE gde1. YENTREVE 20mg g/r capsules gde2. YENTREVE 40mg g/r capsules gde3. CYMBALTA 30mg g/r capsules gde4. *CYMBALTA 60mg g/r capsules gdew. *DULOXETINE 60mg g/r capsules gdex. DULOXETINE 30mg g/r capsules gdey. DULOXETINE 20mg g/r capsules gdez. DULOXETINE 40mg g/r capsules dq6.. SELEGILINE dq61. ELDEPRYL 5mg tablets dq62. ELDEPRYL 10mg tablets dq63. ELDEPRYL 10mg/5mL syrup dq64. *VIVAPRYL 5mg tablets dq65. *VIVAPRYL 10mg tablets dq66. *STILLINE 5mg tablets dq67. *STILLINE 10mg tablets dq68. *CENTRAPRYL 5 tablets dq69. *CENTRAPRYL 10 tablets dq6A. ZELAPAR 1.25mg tablets dq6w. SELEGILINE HCL 1.25mg tablets dq6x. SELEGILINE HCL 10mg/5mL syrup dq6y. SELEGILINE HCL 10mg tablets dq6z. SELEGILINE HCL 5mg tablets Benzodiazepines d14.. FLUNITRAZE d141. ROHYPNOL d14z. FLUNITRAZE d15.. FLURAZEPAM d151. DALMANE d152. DALMANE d153. PAXANE d154. PAXANE d15y. FLURAZEPAM d15z. FLURAZEPAM d16.. LOPRAZOLAM d161. LOPRAZOLAM d162. DORMONOCT d17.. LORMETAZEP d171. LORMETAZEP d172. LORMETAZEP d173. d174. d18.. NITRAZEPAM d181. NITRAZEPAM d182. NITRAZEPAM d183. NITRAZEPAM d184. NITRAZEPAM d185. MOGADON d186. MOGADON d187. NITRADOS d188. d189. REMNOS d18a. REMNOS d18b. d18c. SOMNITE d18d. d18e. UNISOMNIA d18f.
Load more

Recommended publications
  • Dosulepin Prescribing
    SAFETY BULLETIN: DOSULEPIN PRESCRIBING In December 2007, the Medicines and Healthcare Regulatory Agency (MHRA) issued safety advice around prescribing of dosulepin, related to the narrow margin between therapeutic doses and potentially fatal doses. Nevertheless, dosulepin continues to be prescribed widely. Over eight years after the safety advice was published, prescribing of dosulepin in the Dorset area remains high. In the South West area, Dorset CCG was the highest prescriber of dosulepin for the 2015/16 financial year (3.238% of all antidepressant items). Of the 209 CCGs in the UK, Dorset is the fourteenth highest prescriber of dosulepin, and well above the national average of 2.111%. The following points summarise the reasons that dosulepin is not recommended for prescribing nationally, and in Dorset: Dosulepin has a small margin of safety between the (maximum) therapeutic dose and potentially fatal doses. The NICE guideline on depression in adults recommends that dosulepin should not be prescribed for adults with depression because evidence supporting its tolerability relative to other antidepressants is outweighed by the increased cardiac risk and toxicity in overdose. Dosulepin has also been used ‘off label’ in other indications such as fibromyalgia and neuropathic pain. However the evidence for use in in this way is weak, and is not recommended. The lethal dose of dosulepin is relatively low and can be potentiated by alcohol and other CNS depressants. Dosulepin overdose is associated with high mortality and can occur rapidly, even before hospital treatment can be received. Onset of toxicity occurs within 4-6 hours. Every year, up to 200 people in England and Wales fatally overdose with dosulepin.
    [Show full text]
  • Dose Equivalents of Antidepressants Evidence-Based Recommendations
    Journal of Affective Disorders 180 (2015) 179–184 Contents lists available at ScienceDirect Journal of Affective Disorders journal homepage: www.elsevier.com/locate/jad Research report Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials Yu Hayasaka a,n, Marianna Purgato b, Laura R Magni c, Yusuke Ogawa a, Nozomi Takeshima a, Andrea Cipriani b,d, Corrado Barbui b, Stefan Leucht e, Toshi A Furukawa a a Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Yoshida Konoe-cho, Sakyo- ku, Kyoto 606-8501, Japan b Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Policlinico “G.B.Rossi”, Pzz.le L.A. Scuro, 10, Verona 37134, Italy c Psychiatric Unit, Istituto di Ricovero e Cura a Carattere Scientifico, Centro San Giovanni di Dio, Fatebenefratelli, Brescia, Italy d Department of Psychiatry, University of Oxford, Oxford, UK e Department of Psychiatry and Psychotherapy, Technische Universität München, Klinikum rechts der Isar, Ismaningerstr. 22, 81675 Munich, Germany article info abstract Article history: Background: Dose equivalence of antidepressants is critically important for clinical practice and for Received 4 February 2015 research. There are several methods to define and calculate dose equivalence but for antidepressants, Received in revised form only daily defined dose and consensus methods have been applied to date. The purpose of the present 10 March 2015 study is to examine dose equivalence of antidepressants by a less arbitrary and more systematic method. Accepted 12 March 2015 Methods: We used data from all randomized, double-blind, flexible-dose trials comparing fluoxetine or Available online 31 March 2015 paroxetine as standard drugs with any other active antidepressants as monotherapy in the acute phase Keywords: treatment of unipolar depression.
    [Show full text]
  • Appendix A: Potentially Inappropriate Prescriptions (Pips) for Older People (Modified from ‘STOPP/START 2’ O’Mahony Et Al 2014)
    Appendix A: Potentially Inappropriate Prescriptions (PIPs) for older people (modified from ‘STOPP/START 2’ O’Mahony et al 2014) Consider holding (or deprescribing - consult with patient): 1. Any drug prescribed without an evidence-based clinical indication 2. Any drug prescribed beyond the recommended duration, where well-defined 3. Any duplicate drug class (optimise monotherapy) Avoid hazardous combinations e.g.: 1. The Triple Whammy: NSAID + ACE/ARB + diuretic in all ≥ 65 year olds (NHS Scotland 2015) 2. Sick Day Rules drugs: Metformin or ACEi/ARB or a diuretic or NSAID in ≥ 65 year olds presenting with dehydration and/or acute kidney injury (AKI) (NHS Scotland 2015) 3. Anticholinergic Burden (ACB): Any additional medicine with anticholinergic properties when already on an Anticholinergic/antimuscarinic (listed overleaf) in > 65 year olds (risk of falls, increased anticholinergic toxicity: confusion, agitation, acute glaucoma, urinary retention, constipation). The following are known to contribute to the ACB: Amantadine Antidepressants, tricyclic: Amitriptyline, Clomipramine, Dosulepin, Doxepin, Imipramine, Nortriptyline, Trimipramine and SSRIs: Fluoxetine, Paroxetine Antihistamines, first generation (sedating): Clemastine, Chlorphenamine, Cyproheptadine, Diphenhydramine/-hydrinate, Hydroxyzine, Promethazine; also Cetirizine, Loratidine Antipsychotics: especially Clozapine, Fluphenazine, Haloperidol, Olanzepine, and phenothiazines e.g. Prochlorperazine, Trifluoperazine Baclofen Carbamazepine Disopyramide Loperamide Oxcarbazepine Pethidine
    [Show full text]
  • Chlorphenamine Maleate)
    Package leaflet: Information for the patient Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate) Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor or nurse. − If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Chlorphenamine is and what it is used for 2. What you need to know before Chlorphenamine is given 3. How Chlorphenamine is given 4. Possible side effects 5. How to store Chlorphenamine 6. Contents of the pack and other information 1. What Chlorphenamine is and what it is used for Chlorphenamine 10 mg/ml Solution for Injection contains the active ingredient chlorphenamine maleate which is an antihistamine. Chlorphenamine is indicated in adults and children (aged 1 month to 18 years) for the treatment of acute allergic reactions. These medicines inhibit the release of histamine into the body that occurs during an allergic reaction. This product relieves some of the main symptoms of a severe allergic reaction. 2. What you need to know before Chlorphenamine is given You MUST NOT be given Chlorphenamine: if you are allergic to chlorphenamine maleate or any of the other ingredients of this medicine (listed in section 6) if you have had monoamine oxidase inhibitor (MAOI) antidepressive treatment within the past 14 days. Warnings and precautions Talk to your doctor or nurse before you are given this medicine if you: are being treated for an overactive thyroid or enlarged prostate gland have epilepsy, raised blood pressure within the eye or glaucoma, very high blood pressure, heart, liver, asthma or other chest diseases.
    [Show full text]
  • Prescribing Trends of Antihistamines in the Outpatient Setting in Al-Kharj
    Prescribing Trends of Antihistamines in the Outpatient Setting in Al-Kharj Nehad J. Ahmed1*, Menshawy A. Menshawy2 1Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia, 2Department of Medicinal chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia Abstract Aim: This study aims to illustrate the prescribing trends of antihistamines in the outpatient setting in Al-Kharj. Materials and Methods: This is a retrospective study that included the evaluation of antihistamines in the outpatient setting in a public hospital in Al-Kharj. The data were collected from the pharmacy-based computer system. Results: The total number of prescriptions that included antihistamines was 799. Most of the prescribed ORIGINAL ARTICLE ARTICLE ORIGINAL antihistamines were first-generation sedating antihistamines (chlorphenamine and diphenhydramine) (66.33%). About 63.20% of the prescribed antihistamines included chlorpheniramine followed by cetirizine (19.27%) and loratadine (14.39%). Conclusion: Antihistamines were prescribed commonly in the outpatient setting mainly first-generation sedating antihistamines. It is recommended to increase the awareness of health- care providers about the efficacy and the side effects of antihistamines and to encourage them to use these agents wisely. Key words: Antihistamines, outpatient, prescribing, trends INTRODUCTION In addition, antihistamines have been classified as sedating antihistamines (first-generation antihistamines) and non- ntihistamines are used in the sedating antihistamines (second-generation antihistamines).[4] management of allergic conditions. Sedating antihistamines include chlorphenamine, clemastine, They are useful for treating the itching hydroxyzine, alimemazine, cyproheptadine, promethazine, A [1] and ketotifen.[4] Non-sedating antihistamines include that results from the release of histamine.
    [Show full text]
  • ZANTAC® 150 (Ranitidine Hydrochloride) Tablets, USP
    PRESCRIBING INFORMATION ZANTAC® 150 (ranitidine hydrochloride) Tablets, USP ZANTAC® 300 (ranitidine hydrochloride) Tablets, USP ZANTAC® 25 (ranitidine hydrochloride effervescent) ® EFFERdose Tablets ® ZANTAC (ranitidine hydrochloride) Syrup, USP DESCRIPTION The active ingredient in ZANTAC 150 Tablets, ZANTAC 300 Tablets, ZANTAC 25 EFFERdose Tablets, and ZANTAC Syrup is ranitidine hydrochloride (HCl), USP, a histamine H2-receptor antagonist. Chemically it is N[2-[[[5-[(dimethylamino)methyl]-2­ furanyl]methyl]thio]ethyl]-N′-methyl-2-nitro-1,1-ethenediamine, HCl. It has the following structure: The empirical formula is C13H22N4O3S•HCl, representing a molecular weight of 350.87. Ranitidine HCl is a white to pale yellow, granular substance that is soluble in water. It has a slightly bitter taste and sulfurlike odor. Each ZANTAC 150 Tablet for oral administration contains 168 mg of ranitidine HCl equivalent to 150 mg of ranitidine. Each tablet also contains the inactive ingredients FD&C Yellow No. 6 Aluminum Lake, hypromellose, magnesium stearate, microcrystalline cellulose, titanium dioxide, triacetin, and yellow iron oxide. Each ZANTAC 300 Tablet for oral administration contains 336 mg of ranitidine HCl equivalent to 300 mg of ranitidine. Each tablet also contains the inactive ingredients croscarmellose sodium, D&C Yellow No. 10 Aluminum Lake, hypromellose, magnesium stearate, microcrystalline cellulose, titanium dioxide, and triacetin. 1 ZANTAC 25 EFFERdose Tablets for oral administration is an effervescent formulation of ranitidine that must be dissolved in water before use. Each individual tablet contains 28 mg of ranitidine HCl equivalent to 25 mg of ranitidine and the following inactive ingredients: aspartame, monosodium citrate anhydrous, povidone, and sodium bicarbonate. Each tablet also contains sodium benzoate.
    [Show full text]
  • 2D6 Substrates 2D6 Inhibitors 2D6 Inducers
    Physician Guidelines: Drugs Metabolized by Cytochrome P450’s 1 2D6 Substrates Acetaminophen Captopril Dextroamphetamine Fluphenazine Methoxyphenamine Paroxetine Tacrine Ajmaline Carteolol Dextromethorphan Fluvoxamine Metoclopramide Perhexiline Tamoxifen Alprenolol Carvedilol Diazinon Galantamine Metoprolol Perphenazine Tamsulosin Amiflamine Cevimeline Dihydrocodeine Guanoxan Mexiletine Phenacetin Thioridazine Amitriptyline Chloropromazine Diltiazem Haloperidol Mianserin Phenformin Timolol Amphetamine Chlorpheniramine Diprafenone Hydrocodone Minaprine Procainamide Tolterodine Amprenavir Chlorpyrifos Dolasetron Ibogaine Mirtazapine Promethazine Tradodone Aprindine Cinnarizine Donepezil Iloperidone Nefazodone Propafenone Tramadol Aripiprazole Citalopram Doxepin Imipramine Nifedipine Propranolol Trimipramine Atomoxetine Clomipramine Encainide Indoramin Nisoldipine Quanoxan Tropisetron Benztropine Clozapine Ethylmorphine Lidocaine Norcodeine Quetiapine Venlafaxine Bisoprolol Codeine Ezlopitant Loratidine Nortriptyline Ranitidine Verapamil Brofaramine Debrisoquine Flecainide Maprotline olanzapine Remoxipride Zotepine Bufuralol Delavirdine Flunarizine Mequitazine Ondansetron Risperidone Zuclopenthixol Bunitrolol Desipramine Fluoxetine Methadone Oxycodone Sertraline Butylamphetamine Dexfenfluramine Fluperlapine Methamphetamine Parathion Sparteine 2D6 Inhibitors Ajmaline Chlorpromazine Diphenhydramine Indinavir Mibefradil Pimozide Terfenadine Amiodarone Cimetidine Doxorubicin Lasoprazole Moclobemide Quinidine Thioridazine Amitriptyline Cisapride
    [Show full text]
  • Drug Induced QT Prolongation and Torsades De Pointes (Tdp)
    Drug induced QT prolongation and Torsades de Pointes (TdP) Mark Friesen, PharmD March 13, 2013 Conflict of Interest None TdP: Learning objectives To review the pathophysiology of QT prolongation and TdP To become aware of the risk factors (including medication- related) for QT prolongation and TdP To understand and apply a systematic approach for dealing with drug interactions that may cause prolonged QT and TdP Clinical Scenario You receive an order for a patient: Levofloxacin 500 mg PO daily Fluconazole 400 mg PO daily Your drug interaction program flags this as a major interaction due to QT prolonging effect of both drugs increasing risk for TdP. What do you do? TdP: History Quinidine associated syncope since 1920’s Congenital syndromes with prolonged QT and syncope or sudden death described in 1950’s, and early 1960’s. 1966 Francois Dessertenne described a specific EKG form of polymorphic VT he termed “torsades de pointes” Over past decade single most common cause of drug withdrawal/restriction from market 9 structurally unrelated non-cardiac drugs: terfenadine, astemizole, grepafloxicin, terodiline, droperidol, terodiline, droperidol, lidoflazaine, sertindole, levomethadyl, cisapride TdP: Definition Polymorphic VT with a preexistant prolonged QT interval Ventricular Action Potential Ca++ Na+ IKr IKs IKr Channel: hERG controlled Delayed repolarization=prolonged QT interval Mechanism of Torsades de Pointes Early afterdepolarizations (extra beat) Transmural reentry (Unusual pathway) Mechanisms Of Drug - Induced QT Prolongation
    [Show full text]
  • The In¯Uence of Medication on Erectile Function
    International Journal of Impotence Research (1997) 9, 17±26 ß 1997 Stockton Press All rights reserved 0955-9930/97 $12.00 The in¯uence of medication on erectile function W Meinhardt1, RF Kropman2, P Vermeij3, AAB Lycklama aÁ Nijeholt4 and J Zwartendijk4 1Department of Urology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; 2Department of Urology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands; 3Pharmacy; and 4Department of Urology, Leiden University Hospital, P.O. Box 9600, 2300 RC Leiden, The Netherlands Keywords: impotence; side-effect; antipsychotic; antihypertensive; physiology; erectile function Introduction stopped their antihypertensive treatment over a ®ve year period, because of side-effects on sexual function.5 In the drug registration procedures sexual Several physiological mechanisms are involved in function is not a major issue. This means that erectile function. A negative in¯uence of prescrip- knowledge of the problem is mainly dependent on tion-drugs on these mechanisms will not always case reports and the lists from side effect registries.6±8 come to the attention of the clinician, whereas a Another way of looking at the problem is drug causing priapism will rarely escape the atten- combining available data on mechanisms of action tion. of drugs with the knowledge of the physiological When erectile function is in¯uenced in a negative mechanisms involved in erectile function. The way compensation may occur. For example, age- advantage of this approach is that remedies may related penile sensory disorders may be compen- evolve from it. sated for by extra stimulation.1 Diminished in¯ux of In this paper we will discuss the subject in the blood will lead to a slower onset of the erection, but following order: may be accepted.
    [Show full text]
  • Efficacy of Dosulepin in Tension Type Headache and Midfacial Pain a Randomised Controlled Study
    IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861.Volume 19, Issue 3 Ser.4 (March. 2020), PP 10-14 www.iosrjournals.org Efficacy of Dosulepin in Tension Type Headache and Midfacial Pain a Randomised Controlled Study Corresponding Author: XXXXX Abstract Introduction: Patients presenting with pain in the facial region are commonly reffered to Otorhinolaryngologist. Due to the various causative factors causing pain in the facial region, the proper diagnosis and more importantly the skill to rule out the sinogenic pain plays an important role in management. Tension type headache and midfacial pain are often misdiagnosed and treated wrongly and thus add to the morbidity of patients. Of all the medications that are used for the treatment, most provide minimal, short term relief with side effects on prolong use. Dosulepin a Tricyclic Antidepressant helps in relieving pain with minimal side effects as compared to other Tricyclic Antidepressants. Aims and Objective: To study the efficacy of dosulepin in patients attending outpatient Department of otorhinolaryngology of Silchar Medical College and Hospital Methods: 130 patients attending outpatient Department of ENT and Head and Neck Surgery of Silchar Medical College & Hospital, from September 2017 to August 2018 with complaints of headache diagnosed as tension type headache and midfacial pain were evaluated. Neurological and radiographic examinations were performed prior to therapy and local cause of pain in the facial region were ruled out. Together with this we also performed psychic evaluation for those patients who could not be withdrawn from current medication and then to start them on our current medication.
    [Show full text]
  • Concentration Dependent Cardiotoxicity of Terodiline in Patients Treated for Urinary Incontinence
    Br HeartJ7 1995;74:53-56 53 Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence Simon H L Thomas, P Daniel Higham, Kenneth Hartigan-Go, Farhad Kamali, Peter Wood, Ronald W F Campbell, Gary A Ford Abstract Terodiline hydrochloride is an antimuscarinic Objective-Terodiline, an antimuscarinic drug with calcium antagonist properties' and calcium antagonist drug, was used to which was used for treating urinary inconti- treat detrusor instability but was with- nence caused by detrusor instability.2 The drawn in 1991 after provoking serious drug was withdrawn in 1991 after reports of ventricular arrhythmias associated with cardiac dysrhythmia including bradycardia, increases in the corrected QT interval heart block, ventricular fibrillation, and ven- (QTc). This research was performed to tricular tachycardia, usually of the torsade de relate drug induced electrocardiographic pointes-type34 and associated with QT pro- changes in asymptomatic recipients to longation. Plasma terodiline concentrations plasma concentrations of the R( +) and were very high in one affected patient. S(-) terodiline enantiomers. Predisposing factors for terodiline associated Setting-Urological and geriatric clinics torsade de pointes were old age, coexisting and wards. ischaemic heart disease, co-prescription of Subjects-Asymptomatic patients taking other cardioactive drugs, and hypokalaemia. terodiline in stable dose. Torsade de pointes is associated with Methods-Electrocardiograms (50 mm/s) abnormal prolongation of the ventricular were collected from patients while they refractory period which results in a long QT were taking terodiline and compared with interval on the electrocardiogram and is often ECGs obtained before or after terodiline. drug induced.5 Increased dispersion of ven- QT interval, heart rate corrected QT tricular recovery may be important in the interval (QTc), and QT dispersion (QTd) development of this arrhythmia and indirect were measured.
    [Show full text]
  • Medication List
    Medication List Walgreens Plus™ members receive discounts on thousands of generic and brand-name medications included on this Medication List, which is divided into two sections, “Value Priced” Medications and “Discounted” Medications*. The price for a medication identified as “Value-Priced” is listed below: Get savings up to 85% off Cash Prices • 30-day-supply drugs cost $5 (tier 1), $10 (tier 2) or $15 (tier 3) on Atorvastatin (generic Lipitor) and • 90-day-supply drugs cost $10 (tier 1), $20 (tier 2) or $30 (tier 3) Rosuvastatin (generic Crestor) †† The Discounted Medications section lists the discounts offered to Walgreens Plus members on other generic and brand-name medications not included in the Value-Priced Medication section. The price for a medication is based on its tier and whether it is a 30-day or 90-day supply†. There may be an additional cost for quanities greater than those listed. This discount prescription pricing applies only to Walgreen Plus members on prescriptions purchased in select Walgreens stores that are not billed to insurance and/or used in combination with other health or pharmacy benefit programs. For further details, see your pharmacist or Walgreens.com/Plus. VALUE GENERICS NAPROXEN 250MG TAB 2 60 180 Antifungal NAPROXEN 500MG TAB 2 60 180 Quantity NAPROXEN 375MG TAB 2 60 180 Drug Name Tier 30 90 NAPROXEN DR 500MG TAB 3 60 180 FLUCONAZOLE 150MG TAB 2 1 3 TERBINAFINE 250MG TAB 2 30 90 Asthma Quantity Antiviral Drug Name Tier 30 90 Quantity ALBUTEROL 0.083% INH SOLN 25X3ML 2 75 225 Drug Name Tier 30 90 AMINOPHYLLINE
    [Show full text]